These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 12810481

  • 1. Cerebrospinal fluid 14-3-3 protein: variability of sporadic Creutzfeldt-Jakob disease, laboratory standards, and quantitation.
    Aksamit AJ.
    Arch Neurol; 2003 Jun; 60(6):803-4. PubMed ID: 12810481
    [No Abstract] [Full Text] [Related]

  • 2. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.
    Geschwind MD, Martindale J, Miller D, DeArmond SJ, Uyehara-Lock J, Gaskin D, Kramer JH, Barbaro NM, Miller BL.
    Arch Neurol; 2003 Jun; 60(6):813-6. PubMed ID: 12810484
    [Abstract] [Full Text] [Related]

  • 3. [Creutzfeldt-Jakob disease: diagnostic value of protein 14-3-3 and neuronal specific enolase assay in cerebrospinal fluid].
    Brandel JP, Beaudry P, Delasnerie-Lauprêtre N, Laplanche JL.
    Rev Neurol (Paris); 1999 Feb; 155(2):148-51. PubMed ID: 10226319
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Discrepancies in the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.
    Sanchez-Valle R, Graus F, Saiz A.
    Arch Neurol; 2004 Apr; 61(4):604. PubMed ID: 15096415
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Use of 14-3-3 in the diagnosis of Creutzfeldt-Jakob disease.
    Green AJ.
    Biochem Soc Trans; 2002 Aug; 30(4):382-6. PubMed ID: 12196099
    [Abstract] [Full Text] [Related]

  • 11. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease.
    Green AJ, Knight RS, Macleod MA, Lowman A, Will RG.
    Neurology; 2001 Apr 10; 56(7):986-7. PubMed ID: 11294951
    [No Abstract] [Full Text] [Related]

  • 12. A novel binding assay for detection of 14-3-3 protein in cerebrospinal fluid from Creutzfeldt-Jakob patients.
    Leuck J, Peoch K, Laplanche JL, Grabar E, Müller WE, Schröder HC.
    Cell Mol Biol (Noisy-le-grand); 2000 Nov 10; 46(7):1291-6. PubMed ID: 11075958
    [Abstract] [Full Text] [Related]

  • 13. Case 28-1999: Creutzfeldt-Jakob disease.
    Zeidler M, Green AJ, Zerr I.
    N Engl J Med; 2000 Jan 27; 342(4):292-3. PubMed ID: 10660389
    [No Abstract] [Full Text] [Related]

  • 14. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.
    Krasnianski A, Meissner B, Schulz-Schaeffer W, Kallenberg K, Bartl M, Heinemann U, Varges D, Kretzschmar HA, Zerr I.
    Arch Neurol; 2006 Jun 27; 63(6):876-80. PubMed ID: 16769870
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Determination of 14-3-3 protein levels in cerebrospinal fluid from Creutzfeldt-Jakob patients by a highly sensitive capture assay.
    Peoc'h K, Schröder HC, Laplanche J, Ramljak S, Müller WE.
    Neurosci Lett; 2001 Apr 06; 301(3):167-70. PubMed ID: 11257424
    [Abstract] [Full Text] [Related]

  • 19. CSF detection of the 14-3-3 protein in unselected patients with dementia.
    Peoc'h K, Beaudry P, Lauprêtre N, Laplanche JL.
    Neurology; 2002 Feb 12; 58(3):509-10. PubMed ID: 11839875
    [No Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B, Boons J, Cras P.
    Clin Neurol Neurosurg; 2005 Aug 12; 107(5):355-60. PubMed ID: 16023527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.